Page last updated: 2024-08-24

n-acetylaspartic acid and Parkinson Disease

n-acetylaspartic acid has been researched along with Parkinson Disease in 50 studies

Research

Studies (50)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	16 (32.00)	18.2507
2000's	15 (30.00)	29.6817
2010's	19 (38.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Butterfield, DA; Hinchie, A; Powell, DK; Ren, X; Swomley, A	1
Arabia, G; Barbagallo, G; Caracciolo, M; Cherubini, A; Morelli, M; Nisticò, R; Novellino, F; Quattrone, A; Rocca, F; Sabatini, U; Salsone, M	1
Moriya, M; Nojo, T; Waragai, M	1
Gröger, A; Klose, U; Kolb, R; Schäfer, R	1
Bergamaschi, MM; Chagas, MH; Crippa, JA; dos Santos, AC; Hallak, JE; Pena-Pereira, MA; Sobreira, ET; Teixeira, AL; Tumas, V; Zuardi, AW	1
Bramanti, P; Ciurleo, R; Di Lorenzo, G; Marino, S	1
Bonanno, L; Bramanti, P; Ciurleo, R; Di Lorenzo, G; Marino, S	1
Bao, F; Caon, C; Chorostecki, J; George, E; Gorden, V; Khan, O; Krstevska, S; Santiago, C; Seraji-Bozorgzad, N; Zak, I	1
Almuqbel, M; Anderson, TJ; Dalrymple-Alford, JC; Keenan, RJ; Livingston, L; MacAskill, MR; Melzer, TR; Myall, DJ; Pitcher, TL; Wood, KL	1
Chen, J; Huang, MH; Liu, Y; Shen, YJ; Wu, G; Xing, Z	1
Camicioli, RM; Gee, M; Hanstock, CC; Martin, WR; Wieler, M	1
Rajasankar, S; Surendran, S	1
Barker, GJ; Blain, CR; Guevara, CA; Leigh, PN; Lythgoe, DJ; Stahl, D	1
Berg, D; Chadzynski, G; Godau, J; Gröger, A; Klose, U	1
Cuellar-Baena, S; Dahlberg, C; Denisov, V; Hall, H; In't Zandt, R; Kirik, D	1
Baudrexel, S; Berg, D; Brockmann, K; Csoti, I; Gasser, T; Hattingen, E; Hauser, AK; Hilker, R; Magerkurth, J; Merten, CD; Pilatus, U; Schulte, C; Srulijes, K	1
Duffy, S; Halliday, G; Lewis, SJ; Naismith, SL; Shine, JM	1
Fukazawa, Y; Mito, Y; Tajima, Y; Yanai, M	1
Delfino, M; García-Sánchez, C; Gironell, A; Gómez-Ansón, B; Kulisevsky, J; Llebaria, G; Pagonabarraga, J; Pascual-Sedano, B; Rotger, R; Ruscalleda, J	1
Gan, R; Huang, B; Huang, Z; Nie, K; Wang, L; Zhang, Y; Zhao, J	1
Aasly, J; Axelson, D; Bakken, IJ; Ehrnholm, B; Nilsen, G; Susann Gribbestad, I	1
Firbank, MJ; Harrison, RM; O'Brien, JT	1
Rottenberg, DA	1
Baik, HM; Choe, BY; Jeun, SS; Kim, BS; Kim, MC; Lee, HK; Lee, JM; Lee, KS; Son, BC; Suh, TS	1
Liu, Y; Ruan, LX; Shang, DS; Yuan, M; Zhang, LJ; Zheng, XN; Zhu, XC	1
Bastos, AC; Camicioli, RM; Emery, DJ; Fisher, NJ; Foster, SL; Hanstock, CC; Korzan, JR	1
Fukatsu, H; Hamada, K; Hirayama, M; Ishigaki, T; Katsuno, M; Okada, Y; Sobue, G; Sugiura, M; Watanabe, H	1
Dincer, A; Hanoglu, L; Meral, H; Ozer, F	1
Aia, P; Gruetter, R; Lowary, J; Oz, G; Terpstra, M; Tkác, I; Tuite, PJ	1
Durif, F; Fraix, V; Kickler, N; Krack, P; Krainik, A; Lamalle, L; Lebas, JF; Pollak, P; Rémy, C; Segebarth, C	1
Berti, C; Bianchi, MC; Bonuccelli, U; Ceravolo, R; Del Dotto, P; Gambaccini, G; Logi, C; Lucetti, C; Murri, L; Rossi, G; Tosetti, M	1
Heerschap, A; Hinshaw, DB; Holshouser, BA; Kolem, H; Komu, M; Masur, H; Möller, HE; Sonninen, P; Vermathen, P; Zijlmans, J	1
Barker, GJ; Davie, CA; Kingsley, DP; Lees, AJ; Miller, PH; Pirtosek, Z	1
Barker, GJ; Davie, CA; Kendall, BE; Marsden, CD; McDonald, WI; Miller, DH; Quinn, N; Tofts, PS; Wenning, GK	1
de Koster, A; Heerschap, A; Horstink, MW; Thijssen, HO; van 't Hof, MA; Zijlmans, JC	1
Block, RE; Bowen, BC; Lampman, DA; Murdoch, JB; Pattany, PM; Quencer, RM; Sanchez-Ramos, J	1
Barker, GJ; Brennan, A; Davie, CA; Miller, DH; Quinn, N; Wenning, GK	1
Akiguchi, I; Handa, J; Inubushi, T; Matsuda, M; Morikawa, S; Shiino, A	1
Chaudhuri, KR; Leigh, PN; Lemmens, G; Williams, SC	1
Aotsuka, A; Hattori, T; Shinotoh, H	1
De Mari, M; Federico, F; Giannini, P; Iliceto, G; Lamberti, P; Lucivero, V; Mezzapesa, DM; Simone, IL	1
Chaudhuri, KR; Dawson, J; Ellis, CM; Leigh, PN; Lemmens, G; Simmons, A; Williams, SC	1
Aminoff, MJ; Cruz, CJ; Graham, SH; Meyerhoff, DJ; Weiner, MW	1
Bertolino, A; Bonavita, S; Hallett, M; Litvan, I; Lundbom, N; Patronas, NJ; Tedeschi, G	1
Choe, BY; Kim, BS; Kim, MC; Lee, HK; Lee, KS; Park, JW; Shinn, KS; Son, BC; Suh, TS	1
Bhattacharya, S; Brooks, DJ; Bryant, DJ; Cox, IJ; Sargentoni, J; Seery, JP; Taylor-Robinson, SD; Turjanski, N	1
Blüml, S; Dubowitz, D; Hoang, TQ; Jacques, DB; Kopyov, OV; Lin, A; Ross, BD; Seymour, K; Tan, J	1
Im, JH; Jeong, Y; Kim, HS; Kim, JS; Sohn, YH	1
Clarke, CE; Lowry, M	1
Bernardini, S; Bianchi, MC; Bonuccelli, U; Del Dotto, P; Gambaccini, G; Lucetti, C; Tosetti, M	1

Reviews

4 review(s) available for n-acetylaspartic acid and Parkinson Disease

Article	Year
Magnetic resonance spectroscopy: an in vivo molecular imaging biomarker for Parkinson's disease? BioMed research international, 2014, Volume: 2014 Topics: Aspartic Acid; Biomarkers; Brain; Choline; Creatine; Humans; Magnetic Resonance Spectroscopy; Molecular Imaging; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity	2014
Parkinson's disease: oxidative stress and therapeutic approaches. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2010, Volume: 31, Issue:5 Topics: Animals; Antioxidants; Aspartic Acid; Brain; Catecholamines; Humans; Lipid Peroxidation; Nitric Oxide; Oxidative Stress; Parkinson Disease; Proteasome Endopeptidase Complex; Ubiquitins	2010
A comprehensive review of proton magnetic resonance spectroscopy studies in dementia and Parkinson's disease. Dementia and geriatric cognitive disorders, 2002, Volume: 14, Issue:2 Topics: Alzheimer Disease; Aspartic Acid; Brain; Choline; Humans; Inositol; Magnetic Resonance Spectroscopy; Parkinson Disease; Reference Values; Temporal Lobe	2002
[Magnetic resonance spectroscopy in Parkinson's disease and multiple system atrophy]. Nihon rinsho. Japanese journal of clinical medicine, 1997, Volume: 55, Issue:1 Topics: Aspartic Acid; Autonomic Nervous System Diseases; Basal Ganglia Diseases; Brain; Choline; Creatine; Diagnosis, Differential; Humans; Magnetic Resonance Spectroscopy; Parkinson Disease; Protons	1997

Trials

6 trial(s) available for n-acetylaspartic acid and Parkinson Disease

Article	Year
Effects of cannabidiol in the treatment of patients with Parkinson's disease: an exploratory double-blind trial. Journal of psychopharmacology (Oxford, England), 2014, Volume: 28, Issue:11 Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain-Derived Neurotrophic Factor; Cannabidiol; Creatine; Double-Blind Method; Female; Humans; Male; Middle Aged; Neuroprotective Agents; Parkinson Disease; Proton Magnetic Resonance Spectroscopy; Putamen; Quality of Life; Severity of Illness Index; Treatment Outcome	2014
MRS study on lentiform nucleus in idiopathic Parkinson's disease with unilateral symptoms. Journal of Zhejiang University. Science, 2004, Volume: 5, Issue:2 Topics: Aged; Aspartic Acid; Biomarkers; Choline; Corpus Striatum; Creatine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Reproducibility of Results; Sensitivity and Specificity	2004
Multiple regional 1H-MR spectroscopy in multiple system atrophy: NAA/Cr reduction in pontine base as a valuable diagnostic marker. Journal of neurology, neurosurgery, and psychiatry, 2004, Volume: 75, Issue:1 Topics: Aspartic Acid; Brain Stem; Case-Control Studies; Cerebral Cortex; Creatine; Diagnosis, Differential; Female; Humans; Hydrogen; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Putamen; Reference Values	2004
Influences of dopaminergic treatment on motor cortex in Parkinson disease: a MRI/MRS study. Movement disorders : official journal of the Movement Disorder Society, 2007, Nov-15, Volume: 22, Issue:15 Topics: Adult; Aged; Aspartic Acid; Choline; Creatinine; Dopamine Agonists; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Parkinson Disease; Pergolide; Protons; Treatment Outcome	2007
Localized proton NMR spectroscopy in the striatum of patients with idiopathic Parkinson's disease: a multicenter pilot study. Magnetic resonance in medicine, 1995, Volume: 33, Issue:5 Topics: Adult; Age Factors; Aged; Aged, 80 and over; Antiparkinson Agents; Aspartic Acid; Carbidopa; Choline; Corpus Striatum; Dopamine Agonists; Drug Combinations; Female; Humans; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Pilot Projects; Protons	1995
Proton magnetic resonance spectroscopy in Parkinson's disease and progressive supranuclear palsy. Journal of neurology, neurosurgery, and psychiatry, 1997, Volume: 62, Issue:3 Topics: Aged; Aspartic Acid; Corpus Striatum; Creatine; Globus Pallidus; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Phosphocreatine; Putamen; Statistics, Nonparametric; Supranuclear Palsy, Progressive	1997

Other Studies

40 other study(ies) available for n-acetylaspartic acid and Parkinson Disease

Article	Year
Profiles of brain oxidative damage, ventricular alterations, and neurochemical metabolites in the striatum of PINK1 knockout rats as functions of age and gender: Relevance to Parkinson disease. Free radical biology & medicine, 2019, 11-01, Volume: 143 Topics: Animals; Aspartic Acid; Biomarkers; Brain; Corpus Striatum; Disease Models, Animal; Female; Gene Knockout Techniques; Glutamine; Glutathione; Inositol; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Neurodegenerative Diseases; Oxidative Stress; Parkinson Disease; Protein Kinases; Rats; Taurine	2019
Thalamic neurometabolic alterations in tremulous Parkinson's disease: A preliminary proton MR spectroscopy study. Parkinsonism & related disorders, 2017, Volume: 43 Topics: Aged; Aspartic Acid; Choline; Creatine; Discriminant Analysis; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Logistic Models; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; ROC Curve; Thalamus; Tomography, Emission-Computed, Single-Photon; Tremor	2017
Decreased N-Acetyl Aspartate/Myo-Inositol Ratio in the Posterior Cingulate Cortex Shown by Magnetic Resonance Spectroscopy May Be One of the Risk Markers of Preclinical Alzheimer's Disease: A 7-Year Follow-Up Study. Journal of Alzheimer's disease : JAD, 2017, Volume: 60, Issue:4 Topics: Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Biomarkers; Cognitive Dysfunction; Disease Progression; Female; Follow-Up Studies; Gyrus Cinguli; Humans; Inositol; Lewy Body Disease; Male; Mental Status and Dementia Tests; Parkinson Disease; Prodromal Symptoms; Proton Magnetic Resonance Spectroscopy; Retrospective Studies; Risk Factors	2017
Dopamine reduction in the substantia nigra of Parkinson's disease patients confirmed by in vivo magnetic resonance spectroscopic imaging. PloS one, 2014, Volume: 9, Issue:1 Topics: Aged; Aspartic Acid; Case-Control Studies; Choline; Creatine; Dopamine; Humans; Magnetic Resonance Imaging; Middle Aged; Parkinson Disease; Substantia Nigra	2014
Metabolic changes in de novo Parkinson's disease after dopaminergic therapy: A proton magnetic resonance spectroscopy study. Neuroscience letters, 2015, Jul-10, Volume: 599 Topics: Antiparkinson Agents; Aspartic Acid; Case-Control Studies; Choline; Creatine; Dopamine Agonists; Female; Humans; Indoles; Magnetic Resonance Imaging; Male; Middle Aged; Motor Cortex; Parkinson Disease; Proton Magnetic Resonance Spectroscopy	2015
Longitudinal study of the substantia nigra in Parkinson disease: A high-field (1) H-MR spectroscopy imaging study. Movement disorders : official journal of the Movement Disorder Society, 2015, Volume: 30, Issue:10 Topics: Aged; Aspartic Acid; Biomarkers; Creatine; Female; Humans; Longitudinal Studies; Male; Middle Aged; Parkinson Disease; Proton Magnetic Resonance Spectroscopy; Substantia Nigra	2015
Metabolite ratios in the posterior cingulate cortex do not track cognitive decline in Parkinson's disease in a clinical setting. Parkinsonism & related disorders, 2016, Volume: 22 Topics: Aged; Aged, 80 and over; Aspartic Acid; Bayes Theorem; Case-Control Studies; Choline; Cognitive Dysfunction; Creatine; Dementia; Disease Progression; Female; Gyrus Cinguli; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Superior Sagittal Sinus	2016
Proton MR Spectroscopy for Monitoring Pathologic Changes in the Substantia Nigra and Globus Pallidus in Parkinson Disease. AJR. American journal of roentgenology, 2016, Volume: 206, Issue:2 Topics: Aged; Aspartic Acid; Creatine; Female; Globus Pallidus; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Protons; Retrospective Studies; Severity of Illness Index; Substantia Nigra	2016
Intact presupplementary motor area function in early, untreated Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2008, Sep-15, Volume: 23, Issue:12 Topics: Aged; Aspartic Acid; Case-Control Studies; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Parkinson Disease	2008
Quantitative magnetic resonance spectroscopic imaging in Parkinson's disease, progressive supranuclear palsy and multiple system atrophy. European journal of neurology, 2010, Volume: 17, Issue:9 Topics: Aged; Aspartic Acid; Basal Ganglia Diseases; Biomarkers; Female; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Neurons; Parkinson Disease; Predictive Value of Tests; Supranuclear Palsy, Progressive	2010
Three-dimensional magnetic resonance spectroscopic imaging in the substantia nigra of healthy controls and patients with Parkinson's disease. European radiology, 2011, Volume: 21, Issue:9 Topics: Aged; Aspartic Acid; Case-Control Studies; Choline; Creatine; Female; Humans; Imaging, Three-Dimensional; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Reference Values; Sensitivity and Specificity; Severity of Illness Index; Substantia Nigra	2011
Magnetic resonance spectroscopic methods for the assessment of metabolic functions in the diseased brain. Current topics in behavioral neurosciences, 2012, Volume: 11 Topics: Alzheimer Disease; Aspartic Acid; Brain; Humans; Isotopes; Magnetic Resonance Spectroscopy; Parkinson Disease; Protons	2012
GBA-associated PD. Neurodegeneration, altered membrane metabolism, and lack of energy failure. Neurology, 2012, Jul-17, Volume: 79, Issue:3 Topics: Adenosine Diphosphate; Adult; Age of Onset; Aged; Algorithms; Aspartic Acid; Brain Chemistry; Choline; Creatine; DNA; Energy Metabolism; Female; Glucosylceramidase; Humans; Image Processing, Computer-Assisted; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Membranes; Middle Aged; Mitochondria; Nerve Degeneration; Neurons; Parkinson Disease; Phospholipids; Software	2012
Anterior cingulate integrity: executive and neuropsychiatric features in Parkinson's disease. Movement disorders : official journal of the Movement Disorder Society, 2012, Sep-01, Volume: 27, Issue:10 Topics: Aged; Aspartic Acid; Case-Control Studies; Cognition Disorders; Creatine; Female; Gyrus Cinguli; Humans; Linear Models; Magnetic Resonance Spectroscopy; Male; Mental Disorders; Mental Status Schedule; Middle Aged; Neuropsychological Tests; Parkinson Disease	2012
Unusual basal ganglia lesions in a diabetic uraemic patient proven to be demyelination: first pathological observation. BMJ case reports, 2012, Sep-03, Volume: 2012 Topics: Aspartic Acid; Basal Ganglia; Basal Ganglia Diseases; Demyelinating Diseases; Diabetic Nephropathies; Diagnosis, Differential; Diffusion Magnetic Resonance Imaging; Follow-Up Studies; Humans; Japan; Macrophages; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Myelinolysis, Central Pontine; Neurologic Examination; Parkinson Disease; Putamen; Shock, Septic; Uremia	2012
Spectroscopic changes associated with mild cognitive impairment and dementia in Parkinson's disease. Dementia and geriatric cognitive disorders, 2012, Volume: 34, Issue:5-6 Topics: Aged, 80 and over; Aspartic Acid; Brain Chemistry; Cognition; Cognitive Dysfunction; Data Interpretation, Statistical; Dementia; Disease Progression; Executive Function; Female; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neuropsychological Tests; Parkinson Disease; Prefrontal Cortex; Psychiatric Status Rating Scales; Psychomotor Performance; Temporal Lobe; Tomography, X-Ray Computed	2012
Marked N-acetylaspartate and choline metabolite changes in Parkinson's disease patients with mild cognitive impairment. Parkinsonism & related disorders, 2013, Volume: 19, Issue:3 Topics: Aged; Aspartic Acid; Biomarkers; Brain; Brain Chemistry; Choline; Cognitive Dysfunction; Early Diagnosis; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease	2013
Applications of neural network analyses to in vivo 1H magnetic resonance spectroscopy of Parkinson disease patients. Journal of magnetic resonance imaging : JMRI, 2002, Volume: 16, Issue:1 Topics: Aged; Aspartic Acid; Basal Ganglia; Case-Control Studies; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Neural Networks, Computer; Parkinson Disease	2002
Why Rome trembles: "E avanti a lui tremava tutta Roma!" (Tosca, Act II). Neurology, 2003, Apr-22, Volume: 60, Issue:8 Topics: Aspartic Acid; Cerebellum; Choline; Creatine; Essential Tremor; Humans; Magnetic Resonance Spectroscopy; Parkinson Disease; Raphe Nuclei; Receptor, Serotonin, 5-HT1A; Tomography, Emission-Computed	2003
Proton MR spectroscopic changes in Parkinson's diseases after thalamotomy. European journal of radiology, 2003, Volume: 47, Issue:3 Topics: Adult; Aspartic Acid; Brain; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Postoperative Period; Protons; Stereotaxic Techniques; Thalamus; Treatment Outcome; Tremor	2003
Posterior cingulate metabolic changes occur in Parkinson's disease patients without dementia. Neuroscience letters, 2004, Jan-16, Volume: 354, Issue:3 Topics: Aged; Aspartic Acid; Case-Control Studies; Choline; Cognition; Creatine; Female; Gyrus Cinguli; Humans; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Mental Status Schedule; Middle Aged; Parkinson Disease	2004
Brainstem 1H-MR spectroscopy in patients with Parkinson's disease with REM sleep behavior disorder and IPD patients without dream enactment behavior. Clinical neurology and neurosurgery, 2006, Volume: 108, Issue:2 Topics: Aged; Aspartic Acid; Brain Stem; Case-Control Studies; Choline; Creatine; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Prospective Studies; REM Sleep Behavior Disorder	2006
Proton MRS of the unilateral substantia nigra in the human brain at 4 tesla: detection of high GABA concentrations. Magnetic resonance in medicine, 2006, Volume: 55, Issue:2 Topics: Aspartic Acid; Feasibility Studies; gamma-Aminobutyric Acid; Glutamic Acid; Glutathione; Humans; Magnetic Resonance Spectroscopy; Parkinson Disease; Protons; Substantia Nigra	2006
Glutamate measurement in Parkinson's disease using MRS at 3 T field strength. NMR in biomedicine, 2007, Volume: 20, Issue:8 Topics: Antiparkinson Agents; Aspartic Acid; Corpus Striatum; Creatine; gamma-Aminobutyric Acid; Glutamic Acid; Glutamine; Humans; Levodopa; Magnetic Resonance Spectroscopy; Parkinson Disease; Reference Values	2007
Magnetic resonance spectroscopic study of parkinsonism related to boxing. Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 58, Issue:6 Topics: Aged; Aspartic Acid; Boxing; Corpus Striatum; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease	1995
Differentiation of multiple system atrophy from idiopathic Parkinson's disease using proton magnetic resonance spectroscopy. Annals of neurology, 1995, Volume: 37, Issue:2 Topics: Adult; Aged; Aspartic Acid; Atrophy; Basal Ganglia; Brain Diseases; Choline; Creatine; Diagnosis, Differential; Globus Pallidus; Humans; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Protons; Putamen	1995
Proton magnetic resonance spectroscopy in suspected vascular ischemic parkinsonism. Acta neurologica Scandinavica, 1994, Volume: 90, Issue:6 Topics: Aged; Aspartic Acid; Brain; Brain Ischemia; Brain Mapping; Energy Metabolism; Female; Humans; Intracranial Arteriosclerosis; Lactates; Lactic Acid; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Regional Blood Flow	1994
Proton MR spectroscopy of the brain in 14 patients with Parkinson disease. AJNR. American journal of neuroradiology, 1995, Volume: 16, Issue:1 Topics: Adult; Aged; Aged, 80 and over; Aspartic Acid; Brain; Choline; Creatine; Dementia; Energy Metabolism; Female; Humans; Lactates; Levodopa; Magnetic Resonance Spectroscopy; Male; Middle Aged; Occipital Lobe; Oxidation-Reduction; Parkinson Disease; Phosphocreatine; Protons	1995
MRS to differentiate multiple system atrophy from idiopathic Parkinson's disease. Lancet (London, England), 1993, Sep-11, Volume: 342, Issue:8872 Topics: Adult; Aged; Aspartic Acid; Basal Ganglia; Central Nervous System Diseases; Creatine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease	1993
Proton magnetic resonance spectroscopy with dementia. Surgical neurology, 1993, Volume: 39, Issue:2 Topics: Adult; Aged; Aged, 80 and over; Alzheimer Disease; Aspartic Acid; Creatine; Dementia; Female; Humans; Hydrocephalus, Normal Pressure; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Protons; Reference Values	1993
Magnetic resonance spectroscopic study of parkinsonism related to boxing. Journal of neurology, neurosurgery, and psychiatry, 1995, Volume: 59, Issue:5 Topics: Aspartic Acid; Boxing; Humans; Magnetic Resonance Spectroscopy; Parkinson Disease; Pilot Projects	1995
Changes in putamen N-acetylaspartate and choline ratios in untreated and levodopa-treated Parkinson's disease: a proton magnetic resonance spectroscopy study. Neurology, 1997, Volume: 49, Issue:2 Topics: Adult; Aged; Antiparkinson Agents; Aspartic Acid; Choline; Creatine; Dopamine Agents; Humans; Levodopa; Magnetic Resonance Spectroscopy; Middle Aged; Parkinson Disease; Phosphocreatine; Protons; Putamen; Reference Values	1997
Proton MR spectroscopic imaging of the striatum in Parkinson's disease. Magnetic resonance imaging, 1997, Volume: 15, Issue:6 Topics: Adult; Aged; Aspartic Acid; Biomarkers; Choline; Corpus Striatum; Creatine; Female; Humans; Magnetic Resonance Imaging; Male; Middle Aged; Parkinson Disease; Thalamus	1997
Proton magnetic resonance spectroscopic imaging in progressive supranuclear palsy, Parkinson's disease and corticobasal degeneration. Brain : a journal of neurology, 1997, Volume: 120 ( Pt 9) Topics: Aged; Aged, 80 and over; Aspartic Acid; Brain; Brain Diseases; Choline; Creatine; Female; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Nerve Degeneration; Parkinson Disease; Phosphocreatine; Protons; Supranuclear Palsy, Progressive; Tissue Distribution	1997
Neuronal laterality in Parkinson's disease with unilateral symptom by in vivo 1H magnetic resonance spectroscopy. Investigative radiology, 1998, Volume: 33, Issue:8 Topics: Adult; Aged; Aspartic Acid; Brain Chemistry; Choline; Creatine; Female; Globus Pallidus; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Parkinson Disease; Putamen; Substantia Nigra	1998
A proton magnetic resonance spectroscopy study of the striatum and cerebral cortex in Parkinson's disease. Metabolic brain disease, 1999, Volume: 14, Issue:1 Topics: Aged; Aspartic Acid; Cerebral Cortex; Choline; Corpus Striatum; Creatine; Female; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Movement Disorders; Parietal Lobe; Parkinson Disease; Reference Values; Temporal Lobe	1999
In vivo magnetic resonance spectroscopy of human fetal neural transplants. NMR in biomedicine, 1999, Volume: 12, Issue:4 Topics: Adult; Aspartic Acid; Brain; Fetal Tissue Transplantation; Humans; Huntington Disease; Magnetic Resonance Imaging; Magnetic Resonance Spectroscopy; Parkinson Disease	1999
The brain lesion responsible for parkinsonism after carbon monoxide poisoning. Archives of neurology, 2000, Volume: 57, Issue:8 Topics: Aspartic Acid; Brain Chemistry; Carbon Monoxide Poisoning; Carrier Proteins; Choline; Cognition Disorders; Dopamine Plasma Membrane Transport Proteins; Female; Humans; Magnetic Resonance Imaging; Male; Membrane Glycoproteins; Membrane Transport Proteins; Middle Aged; Nerve Tissue Proteins; Parkinson Disease; Phosphocreatine; Tomography, Emission-Computed, Single-Photon	2000
Basal ganglia metabolite concentrations in idiopathic Parkinson's disease and multiple system atrophy measured by proton magnetic resonance spectroscopy. European journal of neurology, 2000, Volume: 7, Issue:6 Topics: Adult; Aged; Aspartic Acid; Basal Ganglia; Choline; Creatine; Glutamic Acid; Glutamine; Humans; Magnetic Resonance Spectroscopy; Male; Middle Aged; Multiple System Atrophy; Parkinson Disease; Pilot Projects; Reference Values	2000
Proton magnetic resonance spectroscopy (1H-MRS) of motor cortex and basal ganglia in de novo Parkinson's disease patients. Neurological sciences : official journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology, 2001, Volume: 22, Issue:1 Topics: Aged; Aspartic Acid; Basal Ganglia; Brain Chemistry; Choline; Creatine; Female; Humans; Inositol; Magnetic Resonance Spectroscopy; Male; Middle Aged; Motor Cortex; Parkinson Disease	2001